A detailed history of First United Bank & Trust transactions in Novartis Ag stock. As of the latest transaction made, First United Bank & Trust holds 200 shares of NVS stock, worth $20,856. This represents 0.01% of its overall portfolio holdings.

Number of Shares
200
Previous 230 13.04%
Holding current value
$20,856
Previous $24,000 4.17%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$106.13 - $120.89 $3,183 - $3,626
-30 Reduced 13.04%
200 $23,000
Q2 2024

Aug 12, 2024

SELL
$92.57 - $107.37 $17,032 - $19,756
-184 Reduced 44.44%
230 $24,000
Q4 2023

Feb 07, 2024

BUY
$92.27 - $101.54 $38,199 - $42,037
414 New
414 $41,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track First United Bank & Trust Portfolio

Follow First United Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First United Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on First United Bank & Trust with notifications on news.